A
$ Value
$0
Shares
1,822,471
Price
$0
Filed
Jul 28
Insider
Name
Ng George K
Title
Chief Executive Officer
CIK
0001638744
Roles
Director
Officer
Transaction Details
Transaction Date
2025-07-24
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,922,471
Footnotes
Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,859,318 shares are subject to stockholder approval of the revised Omnibus Plan. | Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.
Filing Info
Ng George K's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | PCSA | ▲ | $5K ★ |
| 2026-03-31 | PCSA | ▲ | $5K |
| 2026-02-12 | HURA | A | $0 |
| 2025-10-01 | PCSA | A | $0 |
| 2025-10-01 | PCSA | A | $0 |
| 2025-07-24 | PCSA | A | $0 |
Other Insiders at PCSA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SKIBSTED RUSSELL
Chief Financial Officer
|
$12K | — | 2026-04-15 |
|
Ng George K
Chief Executive Officer
|
$11K | — | 2026-04-15 |
|
Bigora Sian
Chief Development Officer
|
$11K | — | 2026-04-15 |
|
Guy Wendy
Chief Administrative Officer
|
$9K | — | 2026-04-15 |
|
Young David
Pres. Research & Development
|
$9K | — | 2026-04-15 |
|
Lin Patrick
Chief Business - Strategy Off
|
$8K | — | 2026-04-15 |
| Baluch Khoso | $6K | — | 2026-03-31 |
| Pannu Geraldine | $5K | — | 2026-03-31 |
| Neal James R | $2K | — | 2026-03-31 |